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Abstract 
Background and Purpose: Angioedema is a well-recognized side effect of angiotensin-
converting enzyme inhibitors, but is rarely associated with angiotensin II receptor blockers 
(ARB). Here, we report the first case of a patient on ARB therapy (telmisartan) for 
hypertension who developed serous choroidal detachment localized to the posterior pole 
after sub-Tenon anesthesia for small incision cataract surgery.  
Methods and Results: An 82-year-old Japanese woman who received oral medications for 
hypertension underwent cataract surgery with sub-Tenon anesthesia using 2% Xylocaine® on 
her left eye. Her corrected distance visual acuity improved to 20/25 on the first day after the 
surgery. On the fifth day, however, it decreased to 20/40 and choroidal detachment was 
detected at the posterior pole. We suspected an increase of choroidal vascular permeability 
and started oral steroid therapy. After 1 week, the area of detachment was smaller and her 
acuity improved to 20/20. Subsequently, she underwent cataract surgery without sub-Tenon 
anesthesia on her right eye, and no choroidal detachment occurred.  
Conclusion: This is the first published case of ARB-induced choroidal detachment after 
uncomplicated small incision cataract surgery. Sub-Tenon anesthesia may aggravate 
angioedema associated with ARB therapy, so ophthalmologists should be aware of this rare 
complication. 
 
Introduction 
Telmisartan (Micardis®; Boehringer Ingelheim, Ridgefield, Conn., USA; Astellas, 
Tokyo, Japan) is an orally active angiotensin II receptor blocker (ARB) used for the Case Rep Ophthalmol 2012;3:175–179 
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treatment of hypertension. ARBs are generally a safe alternative for patients who 
cannot tolerate angiotensin-converting enzyme (ACE) inhibitors. The incidence of 
angioedema associated with ACE inhibitor therapy ranges from 0.1 to 1%, whereas the 
reported incidence of ARB-induced angioedema ranges from 0.1 to 0.4% [1]. Fromberg 
et al. [2] reported that a patient on ACE inhibitor therapy for hypertension and 
glomerulonephritis developed circumferential choroidal detachment (CD) after 
uncomplicated cataract surgery. Serous CD generally runs continuously from the pars 
plana or the ora serrata around the eyeball to the equator, and it is rarely confined to 
the posterior pole [3]. Here, we report on a hypertensive patient on ARB therapy who 
developed CD localized to the posterior pole after uncomplicated small incision cataract 
surgery with sub-Tenon anesthesia. 
Case Report 
An 82-year-old Japanese woman had been diagnosed with hypertension 3 years earlier. She was 
initially treated with the calcium channel blocker amlodipine besylate (Norvasc®; Pfizer Inc., New 
York, N.Y., USA) at a dose of 5 mg/day. Telmisartan 40 mg/day was added by her local physician to 
achieve better blood pressure control 1 year after amlodipine treatment had been started. She had no 
known allergies such as to penicillin, aspirin, or nonsteroidal anti-inflammatory drugs (NSAIDs). She 
had not received ACE inhibitors before and there was no history of angioedema in herself or her 
family members. 
In April 2009, bilateral age-related cataracts were diagnosed and cataract surgery was planned for 
her left eye with implantation of a one-piece acrylic intraocular lens (SN60WS; Alcon Inc., Fort Worth, 
Tex., USA). The axial length of her right eye was 25.12 mm and that of her left eye was 24.73 mm, as 
measured with an IOLMaster® (Carl Zeiss Meditec, Jena, Germany). A 2.75-mm superior corneoscleral 
incision was made after 1.0 ml of 2% Xylocaine® had been injected with a blunt 27-G needle from  
1 o’clock for sub-Tenon anesthesia. Then, uncomplicated small incision cataract surgery was 
performed. Acetazolamide was not administered. 
On the first day after the surgery, there was a deep anterior chamber with mild inflammation and 
good self-sealing wound closure, and the intraocular pressure was 14 mm Hg. Her corrected distance 
visual acuity (CDVA) had improved to 20/25. An antibiotic (moxifloxacin; Vegamox®) and 
betamethasone (Rinderon®) was started topically 4 times/day. On the fifth day after the surgery, her 
CDVA was decreased to 20/40 and the intraocular pressure was 15 mm Hg. There was optic capture 
of the intraocular lens and CD was seen at the posterior pole on mydriatic examination (fig. 1a), even 
though there had been no postoperative trauma. Computed tomography showed serous CD but no 
nanophthalmos, scleral hypertrophy, or a tumor (fig. 2). Fluorescein angiography confirmed 
choroidal folds at the site of CD, but there were no significant findings. Indocyanine green 
angiography revealed a slight increase in the permeability of choroidal vessels at the site of CD (fig. 
1b, c). Therefore, we diagnosed inflammatory CD and started oral steroid treatment. After 1 week, her 
CD showed a decrease in both area and thickness, while her CDVA improved to 20/20. Subsequently, 
cataract surgery was performed on her right eye under topical anesthesia while steroid therapy was 
continued, and CD did not occur. Her steroid therapy was tapered within a 2-week period. After 2 
months, choroidal folds were still detected, but the CD had resolved. Three months after the surgery, 
the choroidal folds also disappeared and her CDVA improved to 20/16. Indocyanine green 
angiography demonstrated normal permeability of choroidal vessels at the previous site of CD. 
Discussion 
To our knowledge, this is the first case of CD localized to the posterior pole caused 
by sub-Tenon anesthesia in a hypertensive patient on ARB therapy undergoing 
uncomplicated small incision cataract surgery. In fact, the cause of angioedema Case Rep Ophthalmol 2012;3:175–179 
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associated with ARB therapy is not completely understood. ARBs are usually 
considered to be a safe alternative to ACE inhibitors since the serum level of bradykinin 
is unlikely to be affected. However, angioedema has also been reported in patients 
taking ARBs, suggesting that alternative pathways or mechanisms may be involved in 
this adverse reaction. Although not proven in humans, one possible explanation is that 
secondary stimulation of angiotensin II receptors causes an increase in tissue 
bradykinin which then results in angioedema [4]. 
Known causes of CD include a low intraocular pressure associated with eye surgery 
(e.g. after trabeculetomy and intra- or extracapsular cataract extraction [5]), blunt 
trauma, inflammatory diseases (e.g. scleritis or Harada disease), intraocular tumors, 
uveal effusion syndrome, and treatment with acetazolamide [6]. Angioedema is caused 
by various drugs, including penicillin, aspirin, NSAIDs [7], ACE inhibitors [1, 2, 8], and 
ARBs [1]. Except for ARB therapy, the patient had none of these predisposing factors. 
Occurrence of CD at the posterior pole may have been associated with increased 
permeability of the choroidal vessels caused by localized inflammation. Transient 
elevation of intraorbital pressure induced by sub-Tenon anesthesia may stimulate the 
sclera around the injection site [9] and could cause local inflammation that reaches the 
choroidal layer. In addition, injection of Xylocaine near the vorticose veins may disturb 
the choroidal circulation. These factors could facilitate an increase of vascular 
permeability in the choroid associated with ACE inhibitor or ARB therapy. After 
vascular permeability increases, proteins will fail to pass through the filters of Bruch’s 
membrane and the retinal pigment epithelium, while plasma will enter the 
suprachoroidal space and causes CD [10]. This mechanism could account for the 
occurrence of CD localized to the injection site after sub-Tenon anesthesia. 
Hypersensitivity is unlikely since the patient showed no allergic reaction to Xylocaine 
before the surgery. 
In summary, sub-Tenon anesthesia is an easy and safe method with good efficacy 
that is widely used for ophthalmologic surgery, but we should remember that it can 
sometimes cause choroidal folds or CD as in the present case. In particular, sub-Tenon 
anesthesia can aggravate angioedema associated with ACE inhibitor or ARB therapy, so 
ophthalmologists should be aware of this rare complication. 
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Fig. 1. a Photograph of the left eye showing CD at the posterior pole (arrowheads). b Fluorescein 
angiography of the left eye showing choroidal folds (yellow circle). c Indocyanine green angiography 
showing slightly increased permeability of choroidal vessels in the lesion (yellow circle). 
 
 
 
Fig. 2. Computed tomography of the left eye showing serous CD (arrow). 
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